A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Bibliografske podrobnosti
Main Authors:	Gilks, C, Walker, A, Munderi, P, Kityo, C, Reid, A, Katabira, E, Goodall, R, Grosskurth, H, Mugyenyi, P, Hakim, J, Gibb, D
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2013

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
od: Ssali, F, et al.
Izdano: (2006)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
od: Munderi, P, et al.
Izdano: (2010)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
od: Walker, A, et al.
Izdano: (2010)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
od: Walker, A, et al.
Izdano: (2012)

DART and laboratory monitoring of HIV treatment Reply
od: Walker, A, et al.
Izdano: (2010)

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
od: Stöhr, W, et al.
Izdano: (2011)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study.
od: Gomo, Z, et al.
Izdano: (2014)

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
od: Reid, A, et al.
Izdano: (2008)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
od: Kityo, C, et al.
Izdano: (2014)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
od: Mugyenyi, P, et al.
Izdano: (2010)

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models.
od: Ford, D, et al.
Izdano: (2015)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
od: Lara, A, et al.
Izdano: (2012)

The impact of different CD4 cell-count monitoring and switching strategies on mortality in HIV-infected African adults on antiretroviral therapy: an application of dynamic marginal structural models
od: Ford, D, et al.
Izdano: (2015)

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min
od: Ross, LL, et al.
Izdano: (2019)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
od: Muyingo, S, et al.
Izdano: (2008)

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
od: Kikaire, B, et al.
Izdano: (2007)

Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
od: Ndembi, N, et al.
Izdano: (2010)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
od: Cissy Kityo, et al.
Izdano: (2014-01-01)

Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.
od: Kityo, C, et al.
Izdano: (2010)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
od: Antonieta Medina Lara, et al.
Izdano: (2012-01-01)

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min.
od: Lisa L Ross, et al.
Izdano: (2019-01-01)

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.
od: Serwanga, J, et al.
Izdano: (2011)

MONITORING THE SHIFT OF RAINFED LINE OF 250 mm OVER IRAQ
od: Y. K. Al-Timimi, et al.
Izdano: (2024-06-01)

Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae.
od: Stöhr, W, et al.
Izdano: (2008)

A perpendicular field electromagnet with a 250 mm access bore
od: Petrović, Alexander Paul, et al.
Izdano: (2021)

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.
od: Munderi, P, et al.
Izdano: (2011)

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
od: Gibb, D, et al.
Izdano: (2012)

Evolution of protease inhibitor resistance in HIV-1-infected patients failing protease inhibitor monotherapy as second-line therapy in low-income countries: an observational analysis within the EARNEST randomised trial
od: Thompson, J, et al.
Izdano: (2018)

Homogenization Path Based on 250 mm × 280 mm Bloom under Mixed Light and Heavy Presses: Simulation and Industrial Studies
od: Aiguo Dang, et al.
Izdano: (2024-05-01)

CD8+ T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+ T Cells <200 Cell/μL: The DART Trial STI Substudy
od: Jennifer Serwanga, et al.
Izdano: (2011-01-01)

Academic promotion criteria: Success or fail?
od: Cenk Demirdover
Izdano: (2020-01-01)

Comparison of the Flow Field in a Slab Continuous Casting Mold between the Thicknesses of 180 mm and 250 mm by High Temperature Quantitative Measurement and Numerical Simulation
od: Yibo Liu, et al.
Izdano: (2021-11-01)

Radiological signs supporting idiopathic intracranial hypertension in symptomatic patients with lumbar puncture opening pressure < 250 mm
od: Anat Horev, et al.
Izdano: (2024-08-01)

Lack of minority K65R-resistant viral populations detected after repeated treatment interruptions of tenofovir/zidovudine and lamivudine in a resource-limited setting.
od: McCormick, A, et al.
Izdano: (2010)

Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
od: Diana M Gibb, et al.
Izdano: (2012-01-01)

Impact of sub-optimal HIV viral control on activated T-cells: an earnest sub study
od: Arrigoni, FIF, et al.
Izdano: (2023)

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.
od: Kiwuwa-Muyingo, S, et al.
Izdano: (2012)

Opportunities for improving the efficiency of paediatric HIV treatment programmes.
od: Revill, P, et al.
Izdano: (2015)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial
od: Parikh, S, et al.
Izdano: (2013)

250 home-based jobs /
od: 256015 Olson, Scott C.
Izdano: (1990)

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Podobne knjige/članki

Podobne knjige/članki